Aortic valve malfunction, age under 60 years

I9_AORTVALV_EARLY

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE < 60 Registry filters: Hospital discharge: ICD-10 — I35.0, I35.1, I35.2, I35.8 Hospital discharge: ICD-9 — 4242[A-C] Cause of death: ICD-10 — I35.0, I35.1, I35.2, I35.8 Cause of death: ICD-9 — 4242[A-C] 2 out of 7 registries used, show all original rules.	3683
4. Check minimum number of events None	3683
5. Include endpoints None	3683
6. Filter based on genotype QC (FinnGen only)	3683

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	I9_AORTVALV_EARLY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE < 60
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I35[0-8]
HD_ICD_9	4242[A-C]
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I35[0-8]
COD_ICD_9	4242[A-C]
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Aortic valve malfunction, age under 60 years based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3683	1328	2355
Unadjusted period prevalence (%)	0.83	0.45	1.04
Median age at first event (years)	52.42	52.19	52.55

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3339: Matched controls
33389

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

23.6

323.0

683

359

I35.0

ICD-10 Finland

Aortic (valve) stenosis

71.2

323.0

1487

372

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

205.1

323.0

2284

348

C07AB07

ATC

bisoprolol; oral

4.3

323.0

2117

9606

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

78.0

323.0

916

161

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.8

323.0

1568

3050

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

9.0

323.0

1824

3936

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

6.5

323.0

1538

3870

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

13.3

323.0

994

1034

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

87.0

323.0

793

119

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

22.1

323.0

853

511

B01AA03

ATC

warfarin; systemic

11.6

323.0

1663

2624

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

352.0

323.0

675

Q23.11

ICD-10 Finland

Bicuspid aortic valve

150.5

323.0

615

K83

ICPC

Heart valve disease NOS

52.8

295.0

355

WX872

NOMESCO Finland

Intensive care

9.8

290.3

629

769

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

6.7

267.3

762

1414

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.9

261.3

1011

2698

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

243.3

1936

9583

AB1

AVR mechanical

233.8

234.1

239

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

34.4

215.7

284

I48

ICD-10 Finland

Atrial fibrillation and flutter

4.2

215.6

980

2986

C03CA01

ATC

furosemide; systemic

3.9

207.0

1059

3567

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

137.7

206.1

219

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

23.7

202.3

295

136

B01AB05

ATC

enoxaparin; parenteral

3.3

197.3

1392

5998

AN1

Coronary angiography

4.9

189.3

697

1694

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

10.2

178.8

372

405

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

15.4

169.5

288

203

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.5

150.0

483

991

PD5BD

NOMESCO Finland

Extensive CT of aorta

13.8

144.8

258

202

XF640

NOMESCO Finland

11.2

144.5

285

277

I50.9

ICD-10 Finland

Heart failure, unspecified

4.8

138.4

506

1190

ZXE20

NOMESCO Finland

More than three and less than five hours

3.5

136.7

747

2530

TFP20

NOMESCO Finland

Cardiodefibrillation

4.9

133.2

475

1085

201

Kela drug reimbursment

Chronic cardiac insufficiency

7.6

129.5

322

465

Angiography of the heart and coronary arteries

6.6

126.8

350

586

K84

ICPC

Heart disease other

10.9

126.5

251

246

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

15.1

126.1

215

151

C09AA05

ATC

ramipril; oral

2.8

120.1

1000

4476

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.0

119.7

825

3270

XF404

NOMESCO Finland

Ambulatory ECG

4.0

115.5

516

1458

K78

ICPC

Atrial fibrillation/flutter

5.3

114.5

379

791

Aortic Valve Replacement (AVR)

1114.3

111.1

108

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

61.4

111.0

130

XF402

NOMESCO Finland

ECG with work load test

3.5

110.9

601

1987

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.5

108.5

346

690

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

104.6

1151

5931

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

6.5

104.6

288

477

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

11.8

103.7

197

176

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

43.5

101.3

126

I35.8

ICD-10 Finland

Other aortic valve disorders

93.9

98.6

109

C03DA01

ATC

spironolactone; oral

3.7

97.9

474

1423

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

29.4

97.7

133

XFE00

NOMESCO Finland

Epicardial ultrasonography

9.0

97.5

215

254

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.8

96.9

348

789

I34.1

ICD-10 Finland

Mitral (valve) prolapse

7.4

96.9

241

345

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

5.2

95.5

316

655

C01AA05

ATC

digoxin; systemic

5.4

95.4

305

607

C07AB02

ATC

metoprolol; systemic

2.8

92.4

709

2948

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

124.8

90.4

K99

ICPC

Cardiovascular disease other

8.6

87.4

197

241

C01BD01

ATC

amiodarone; systemic

6.9

84.7

222

342

Q25.1

ICD-10 Finland

Coarctation of aorta

81.5

84.5

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

83.7

686

2947

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

7.0

78.4

202

303

J01CA04

ATC

amoxicillin; systemic

2.3

78.2

2748

22423

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

35.9

78.0

101

I50.0

ICD-10 Finland

Congestive heart failure

5.2

77.1

252

512

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

22.5

75.7

111

Catheterization and pressure measurement of the left side of the heart

13.1

75.5

136

108

I44.2

ICD-10 Finland

Atrioventricular block, complete

9.0

74.3

162

187

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

73.7

477

1754

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

36.2

73.6

I50.1

ICD-10 Finland

Left ventricular failure

5.3

72.0

234

472

207

Kela drug reimbursment

Chronic arrhythmias

2.9

69.1

477

1827

ZXD05

NOMESCO Finland

Urgent procedure

2.1

68.7

1101

6457

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

343.9

67.8

211

AVR mechanical

234.7

67.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.9

65.8

1806

12882

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

65.7

1467

9721

AB2

AVR bio, stent

38.7

65.3

R06.0

ICD-10 Finland

Dyspnoea

2.2

64.0

808

4254

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.4

63.8

200

386

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

9.3

62.1

133

149

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

14.7

60.5

103

R4110

NOMESCO Finland

Physiotherapy

2.0

60.3

984

5749

WX892

NOMESCO Finland

Monitored bed care

3.1

59.1

353

1221

N02BE01

ATC

paracetamol; systemic, rectal

2.1

58.8

2793

23708

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.7

58.4

209

467

I97.0

ICD-10 Finland

Postcardiotomy syndrome

25.4

58.2

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

155.2

58.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

57.9

979

5781

C10AA05

ATC

atorvastatin; oral

1.9

57.5

1284

8388

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

4.7

55.7

198

439

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

55.6

932

5469

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.4

55.0

283

875

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.3

54.7

293

934

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

77.7

54.1

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

53.6

766

4207

Z2221

NOMESCO Finland

Medical doctor

1.9

53.2

945

5648

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.4

52.8

165

317

Catheterization and pressure measurement of the right side of the heart

29.7

52.0

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

21.6

51.5

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.0

51.0

216

567

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

50.9

1262

8435

C07AA07

ATC

sotalol; systemic

5.2

49.8

162

326

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

21.9

49.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.9

49.5

324

1186

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

8.5

48.7

109

132

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

18.7

48.5

AA1AD

NOMESCO Finland

CT of head and brain

2.0

48.0

751

4248

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

19.6

48.0

205

Kela drug reimbursment

Chronic hypertension

1.9

47.2

804

4694

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

24.4

47.2

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

7.6

47.0

113

153

I35

ICD-10 Finland

Nonrheumatic aortic valve disorders

77.0

47.0

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

9.3

46.3

108

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

15.6

45.4

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

9.8

45.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.5

45.1

139

263

PD5AD

NOMESCO Finland

CT of aorta

7.6

44.7

107

144

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

26.3

44.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

43.7

977

6242

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

32.2

43.3

WW502

NOMESCO Finland

Autotransfusion

14.3

42.7

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

11.3

42.6

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

28.1

42.6

AP1

Catheterization of the left side of the heart

6.9

42.5

109

163

N02AX02

ATC

tramadol; systemic, rectal

1.7

42.2

1402

10068

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

32.9

42.0

AJ2

Reconstruction of the ascending aorta

38.4

41.9

FCA75

NOMESCO Finland

Valve-sparing repair of aortic root (David, Yacoub)

148.5

41.8

PD5BG

NOMESCO Finland

MRI examination of thoracal and abdominal aortta with high intensity magnet

43.1

41.3

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.1

41.0

242

824

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.1

40.8

493

2491

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

35.2

40.4

WX402

NOMESCO Finland

General anaesthesia

2.0

40.3

641

3621

ZXE00

NOMESCO Finland

One hour or less

1.7

39.4

1246

8771

R04.0

ICD-10 Finland

Epistaxis

2.9

39.2

256

932

C10AA01

ATC

simvastatin; oral

1.7

39.2

1235

8681

C08CA01

ATC

amlodipine; oral

1.7

39.2

1062

7149

5273

FHL

Repair with flap prosthesis or graft

202.3

38.9

Z50.0

ICD-10 Finland

Cardiac rehabilitation

8.0

38.2

112

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

38.1

714

4266

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

31.7

37.9

74719

ICD-8 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta

53.1

35.4

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.9

35.4

150

394

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

40.5

35.3

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

35.2

609

3528

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.2

34.9

375

1787

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

181.8

34.8

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

19.5

34.4

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.8

33.8

237

901

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

25.1

33.6

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

28.5

33.3

WZC30

NOMESCO Finland

Teaching

2.0

33.1

479

2589

C10AX09

ATC

ezetimibe; oral

2.1

32.3

399

2021

C09AA02

ATC

enalapril; systemic

1.9

32.2

568

3302

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.9

31.8

203

727

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

8.5

31.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

31.4

266

1126

I47.1

ICD-10 Finland

Supraventricular tachycardia

3.2

31.4

176

578

I47.2

ICD-10 Finland

Ventricular tachycardia

4.8

31.4

107

228

TK800

NOMESCO Finland

Hemodialysis

4.0

31.3

128

326

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

30.8

1142

8242

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

30.6

543

3156

I71.09

ICD-10 Finland

Aortic dissection [regardless of location]

17.4

30.5

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

5.3

30.4

180

Q87.4

ICD-10 Finland

Marfan syndrome

38.4

30.2

I49.5

ICD-10 Finland

Sick sinus syndrome

4.5

30.2

110

251

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

30.1

655

4070

R50.9

ICD-10 Finland

Fever, unspecified

1.9

30.1

461

2543

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.5

29.9

244

1011

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

29.3

394

2065

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.3

29.1

110

261

I38

ICD-10 Finland

Endocarditis, valve unspecified

28.2

28.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

28.7

844

5714

C01DA14

ATC

isosorbide mononitrate; oral

2.2

28.6

328

1606

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.2

28.5

320

1554

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.1

28.3

165

557

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

28.2

608

3759

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

28.1

320

1563

A02BC02

ATC

pantoprazole; systemic

1.5

28.1

1946

16080

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.7

27.8

200

769

AP2

Catheterization of the right side of the heart

19.3

27.8

74673

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae aortae

283.7

27.8

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

7.0

27.7

100

K22

ICPC

Risk factor cardiovascular disease

2.8

27.4

182

668

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.0

27.3

162

553

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

26.3

424

2374

R55

ICD-10 Finland

Syncope and collapse

2.1

26.2

302

1480

G45.3

ICD-10 Finland

Amaurosis fugax

5.1

26.2

168

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

26.0

388

2113

SPAT1263

SPAT

Sampling

1.5

25.9

1179

8832

C08CA05

ATC

nifedipine; systemic

2.6

25.8

193

762

7471A

ICD-9 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]

262.5

25.7

K29

ICPC

Cardiovascular sympt/complt other

3.1

25.7

147

490

PD5CD

NOMESCO Finland

Very extensive CT angiography of aorta

9.8

25.7

AP3

Catheterization of the right and left side of the heart

18.8

25.6

C09CA01

ATC

losartan; oral

1.6

25.6

707

4679

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

25.4

1085

8004

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

5.9

25.3

125

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.9

25.2

105

273

FMC96

NOMESCO Finland

Other operation on aortic valve for insufficiency

+∞

25.0

Q21.10

ICD-10 Finland

Persistent ostium secundum

9.6

24.9

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.3

24.8

224

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

10.8

24.5

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

841

2133

4.81

311.61

3.4

2.8

ng/l

206.3

151.2

3.25

793

1909

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1324

4714

3.82

308.49

3.3

2.4

31.4

29.9

12.10

1303

4588

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

928

2450

4.73

307.65

2.5

2.3

ug/l

15.6

8.9

9.72

890

2224

(3022217) INR in Platelet poor plasma by Coagulation assay

1197

3414

4.71

307.65

60.7

19.2

inr

2.2

1.2

23.66

119

518

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2344

7306

7.07

307.65

4.4

3.0

ng/l

1145.3

1110.8

0.13

2166

6139

(3032080) INR in Blood by Coagulation assay

2429

11707

4.16

307.65

32.3

7.8

inr

1.9

1.2

97.66

737

3381

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

896

3238

3.34

192.73

4.2

4.9

u/l

295.3

242.7

11.15

862

3097

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

424

981

4.75

171.02

6.7

3.7

u/ml

0.3

0.27

277

538

(3020779) Urea [Moles/volume] in Serum or Plasma

741

2871

2.98

137.15

12.2

9.4

mmol/l

9.6

9.0

1.43

710

2760

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1584

8972

2.34

132.50

2.6

2.2

u/l

300.8

241.7

1.77

1527

8493

(3023368) Bacteria identified in Blood by Culture

1418

7724

2.36

129.12

6.0

4.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1811

11027

2.26

125.51

4.6

3.3

ng/l

58.7

52.5

0.36

1362

7262

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

867

3854

2.63

121.95

3.6

2.8

21.8

24.2

4.47

769

3353

(3027945) Reticulocytes/100 erythrocytes in Blood

735

3022

2.79

120.50

2.9

3.0

1.8

0.01

688

2725

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1120

5647

2.41

120.02

5.1

3.6

ng/l

2360.1

566.4

1.74

1005

4265

(3004789) Transferrin [Mass/volume] in Serum or Plasma

896

4126

2.55

116.54

3.7

2.7

g/l

2.4

2.3

1.97

863

3882

(3013826) Glucose [Moles/volume] in Serum or Plasma

2495

17709

2.27

113.70

8.7

5.1

mmol/l

6.6

6.8

2.90

2412

16661

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

361

1003

3.88

112.95

4.0

3.2

g/l

3.3

3.6

2.85

346

960

(3022948) Iron [Moles/volume] in Serum or Plasma

930

4433

2.47

111.75

3.7

2.7

umol/l

12.6

13.9

4.79

885

4172

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1277

7104

2.22

106.11

3.0

2.4

—

(3044889) 12 lead EKG panel

2873

22067

2.37

101.82

6.0

3.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

986

5000

2.33

101.74

5.3

4.2

mmol/l

0.8

3.86

941

4737

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

103

11.49

98.72

9.3

6.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2042

13875

2.06

97.52

5.0

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

1504

9142

2.09

97.49

3.2

2.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2209

15455

2.07

97.22

7.5

6.8

umol/l

14.0

11.8

8.15

2124

14763

(3016502) Oxygen saturation in Arterial blood

694

3130

2.50

92.17

14.4

9.2

96.6

95.9

2.63

681

3024

(3003396) Base excess in Arterial blood by calculation

742

3451

2.44

92.16

13.8

8.7

mmol/l

1.1

0.9

0.67

622

2726

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

357

1124

3.41

92.05

4.1

2.8

88.3

91.2

1.41

347

1069

(3014576) Chloride [Moles/volume] in Serum or Plasma

799

3860

2.37

91.00

11.2

8.3

mmol/l

105.2

104.4

5.84

787

3788

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

376

1237

3.27

90.26

2.1

1.8

g/l

1.3

1.5

4.24

252

1079

(3038071) Oxygen [Partial pressure] in Mixed venous blood

11.46

90.04

9.4

6.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

738

3463

2.41

89.64

13.8

8.7

kpa

5.2

5.1

0.52

714

3334

(3027801) Oxygen [Partial pressure] in Arterial blood

737

3463

2.41

89.20

13.8

8.7

kpa

13.2

12.6

1.79

712

3333

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1141

6505

2.09

85.43

2.6

2.2

mg/l

3.2

2.8

4.87

1014

5629

(3002173) Hemoglobin [Mass/volume] in Arterial blood

648

2932

2.47

84.89

14.9

9.6

g/l

115.6

124.4

20.94

633

2835

(3036489) Thrombin time

361

1265

3.06

77.52

3.4

2.5

22.7

21.8

1.17

327

1111

(3023520) Reticulocytes [#/volume] in Blood

526

2271

2.54

75.60

3.0

2.9

e9/l

74.8

71.8

0.99

395

1702

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

306

1000

3.25

73.88

3.6

2.9

188.6

189.4

0.05

297

953

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1832

12812

1.86

71.67

11.9

6.8

mmol/l

1.2

25.40

1723

11760

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

475

2009

2.57

71.04

14.7

10.8

0.7

0.51

475

1993

(3006576) Bicarbonate [Moles/volume] in Blood

108

8.52

69.52

9.3

7.4

mmol/l

25.3

25.0

0.30

101

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1950

14038

1.83

68.14

12.9

7.6

mmol/l

1.2

30.70

1685

11994

(3000991) Gas panel - Venous blood

564

2693

2.29

64.06

14.5

10.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

563

2691

2.29

63.77

12.8

8.7

mmol/l

1.3

1.4

0.68

550

2596

(3024561) Albumin [Mass/volume] in Serum or Plasma

1751

12403

1.78

62.69

7.3

5.5

g/l

35.4

36.0

4.69

1655

11667

(3033658) Prothrombin time (PT) actual/Normal

1244

8019

1.83

60.57

5.9

4.4

74.1

91.2

57.41

1216

7849

(3042936) Bacteria identified in Isolate by Culture

785

4373

2.01

59.45

2.6

2.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

406

1732

2.51

59.15

20.0

11.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

10.32

59.10

10.1

7.2

—

(3013512) EKG study

1265

8291

1.80

57.67

5.5

3.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

172

454

3.93

57.28

8.2

7.0

mg/l

11.1

11.2

0.16

155

425

(3024928) Oxygen saturation in Venous blood

214

664

3.36

55.96

6.7

4.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2816

23326

1.88

55.89

9.9

7.8

u/l

78.9

78.4

0.21

2706

22185

(3003458) Phosphate [Moles/volume] in Serum or Plasma

729

4054

2.00

55.02

10.8

7.3

mmol/l

1.1

1.0

3.40

703

3822

(3019550) Sodium [Moles/volume] in Serum or Plasma

3522

32026

3.28

51.96

28.7

15.0

mmol/l

139.4

139.7

16.73

3481

31323

(3019060) Gas panel - Arterial blood

422

1953

2.31

50.95

9.9

5.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1636

11822

1.69

50.92

3.8

2.8

ug/l

171.4

154.1

0.23

1551

11088

(3023103) Potassium [Moles/volume] in Serum or Plasma

3524

32162

3.22

49.49

29.0

15.1

mmol/l

4.0

11.51

3480

31405

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1502

10684

1.69

49.06

3.7

3.5

u/l

37.5

36.5

0.15

1442

10156

(3027456) Digoxin [Moles/volume] in Serum or Plasma

134

331

4.16

48.84

2.5

2.8

nmol/l

0.8

1.06

101

245

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

744

4320

1.91

48.81

2.0

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1039

6713

1.76

47.96

2.8

1.9

mg/l

1.3

1.2

0.61

789

5129

(3004119) Hemoglobin [Mass/volume] in Venous blood

386

1776

2.31

47.10

6.8

3.8

g/l

122.1

131.7

11.09

377

1735

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

363

1627

2.37

47.05

16.7

11.6

mmol/l

24.5

24.3

0.94

339

1557

(3008152) Bicarbonate [Moles/volume] in Arterial blood

398

1876

2.26

45.81

13.3

7.7

mmol/l

24.5

0.05

378

1755

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

188

610

3.19

45.64

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

537

2847

2.04

45.63

6.3

4.7

kpa

5.8

0.38

525

2772

(3002032) Base excess in Venous blood by calculation

536

2850

2.03

45.15

6.4

4.8

mmol/l

1.7

1.9

0.30

454

2311

(3006315) Basophils [#/volume] in Blood

1966

15329

1.61

42.23

7.7

6.4

e9/l

0.0

0.47

1753

13345

(3013115) Eosinophils [#/volume] in Blood

2017

15851

1.60

41.69

8.0

6.7

e9/l

0.2

0.08

1818

14015

(3001604) Monocytes [#/volume] in Blood

1954

15276

1.59

41.00

7.7

6.4

e9/l

0.6

4.19

1741

13291

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3416

31097

2.36

40.95

23.1

13.3

mg/l

29.0

23.7

16.59

2995

24275

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

271

1141

2.48

40.18

2.5

2.1

ug/l

2.0

1.9

0.08

249

1046

(3019198) Lymphocytes [#/volume] in Blood

1996

15727

1.59

40.15

7.8

6.4

e9/l

1.8

2.0

7.83

1802

13941

(42870588) Differential panel, method unspecified - Blood

1418

10323

1.61

39.86

7.5

6.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

260

1081

2.51

39.59

3.5

2.6

ug/l

481.2

522.2

0.11

253

1033

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

341

1612

2.23

38.75

6.0

5.4

mmol/l

24.0

24.1

0.30

302

1480

(3013707) Erythrocyte sedimentation rate by Westergren method

2631

22242

1.64

38.54

5.0

4.0

mm/h

12.4

10.6

7.36

2497

20818

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

473

2584

1.95

36.41

2.6

2.5

ml/min/173m2

61.5

70.6

4.56

194

953

(3013650) Neutrophils [#/volume] in Blood by Automated count

2159

17544

1.56

36.23

10.4

9.8

e9/l

4.2

4.0

2.65

1938

15352

(3024354) Oxygen [Partial pressure] in Venous blood

435

2325

1.99

35.63

5.0

4.1

kpa

4.9

4.8

0.34

425

2254

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

520

3003

1.85

33.61

1.8

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

9.00

33.33

11.0

5.0

62.0

78.6

2.98

(3018418) pH of Serum or Plasma

1140

8157

1.58

32.96

6.5

4.4

7.4

0.15

264

1600

(3021589) Normoblasts [#/volume] in Blood

1746

13715

1.52

32.94

13.1

9.7

e9/l

0.0

0.03

1493

11290

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

521

3031

1.84

32.84

1.9

1.8

—

(3020891) Body temperature

266

1214

2.28

32.78

7.0

5.1

—

(3019069) Monocytes/100 leukocytes in Blood

1803

14345

1.50

31.45

8.3

6.9

9.0

8.7

3.75

1722

13566

(3006504) Eosinophils/100 leukocytes in Blood

1794

14263

1.50

31.37

8.0

6.6

2.9

0.22

1711

13429

(3022096) Basophils/100 leukocytes in Blood

1749

13856

1.50

30.97

8.0

6.7

0.7

0.14

1668

13062

(3031040) Bacteria [#/volume] in Urine by Automated count

2178

18057

1.50

30.80

4.6

3.8

e6/l

167.7

767.0

1.00

222

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

278

1329

2.18

30.57

4.7

3.4

0.7

0.19

266

1276

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

15.40

29.68

8.4

5.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

150

548

2.81

29.52

1.3

1.2

u/ml

5.8

3.8

0.29

182

(3043409) Potassium [Moles/volume] in Arterial blood

212

919

2.39

29.39

6.2

4.6

mmol/l

4.1

3.9

4.92

203

873

(3018010) Neutrophils/100 leukocytes in Blood

1812

14558

1.48

29.31

7.9

6.4

59.1

56.5

17.39

1732

13764

(3018405) Lactate [Moles/volume] in Arterial blood

236

1077

2.27

29.05

5.8

4.3

mmol/l

1.3

1.4

0.58

236

1059

(3002030) Lymphocytes/100 leukocytes in Blood

1833

14785

1.48

28.91

8.1

6.6

25.6

28.5

27.42

1746

13913

(40758558) Short blood count panel - Blood

1078

7829

1.53

28.26

7.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

209

931

2.32

27.22

2.3

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

143

535

2.74

26.91

1.4

1.2

u/ml

6.3

4.6

0.54

237

(40761511) CBC panel - Blood by Automated count

3481

32721

2.16

25.60

22.1

12.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

559

3556

1.67

25.29

1.9

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

137

4.51

25.21

10.8

8.2

mg/l

3084.7

69.8

0.50

106

(3002582) Erythrocytes [#/volume] in Urine

1169

8798

1.48

25.20

3.8

3.2

e6/l

239.5

90.3

0.59

915

6763

(3051593) INR in Capillary blood by Coagulation assay

5.32

25.11

13.7

10.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1237

9422

1.47

25.06

3.3

2.7

u/l

57.8

58.5

0.12

1159

8794

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

481

2957

1.72

24.68

3.7

3.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

173

747

2.38

24.19

9.4

7.0

iu/ml

274.4

543.7

0.74

117

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

344

1931

1.86

23.97

1.9

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

1082

8088

1.48

23.87

3.7

3.1

e6/l

0.4

0.06

826

6067

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

561

3630

1.64

23.64

10.7

6.3

—

(36304419) Bacteria [Presence] in Urine

1065

7953

1.48

23.55

3.5

3.1

—

(3000850) Epithelial cells [#/volume] in Urine

842

6005

1.52

23.26

3.2

2.6

e6/l

3.7

4.6

1.90

740

5289

(3018095) Leukocytes [#/volume] in Urine

1299

10140

1.43

22.50

4.4

3.7

e6/l

64.9

72.6

0.15

975

7266

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3207

29585

1.65

22.46

20.3

12.1

ml/min/173m2

82.8

84.7

5.21

2839

24571

(3023183) Ammonium ion [Moles/volume] in Plasma

171

777

2.26

21.26

3.5

3.4

umol/l

37.9

37.3

0.09

154

689

(3037467) Urinalysis macro (dipstick) panel - Urine

2287

19824

1.41

21.07

4.8

3.9

—

(3012501) Base excess in Blood by calculation

156

686

2.33

20.95

6.0

4.7

mmol/l

2.5

2.4

0.19

465

(4268621)

103

372

2.82

20.78

2.5

2.4

—

(3010421) pH of Blood

171

792

2.22

20.31

5.7

4.7

7.4

0.74

152

674

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3014

27566

1.51

20.18

4.9

4.2

mu/l

1.9

2.3

1.40

2822

25508

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

276

1530

1.87

19.94

1.5

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

340

2019

1.75

19.56

5.6

4.0

kpa

5.1

0.07

310

1885

(3009343) pH of Capillary blood

335

1990

1.75

19.24

5.6

4.0

7.4

0.65

239

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

333

1979

1.75

19.10

6.8

4.6

ng/l

137.6

89.8

6.02

308

1775

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

324

1917

1.76

18.86

5.6

3.9

mmol/l

1.7

1.6

0.20

252

1450

(3009445) Proteinase 3 Ab [Units/volume] in Serum

246

1340

1.90

18.76

1.5

1.6

u/ml

16.1

18.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

529

3556

1.57

18.72

3.4

3.3

umol/l

10.7

8.3

1.14

474

3162

(3019309) Folate [Moles/volume] in Red Blood Cells

633

4441

1.51

18.41

1.8

1.7

nmol/l

1303.5

1164.8

3.00

505

3457

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

186

931

2.05

18.10

2.1

1.5

g/l

1.2

0.83

170

889

(3042733) HLA Ab [Presence] in Serum

168

3.55

17.73

4.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

260

3.00

17.58

1.4

e6/l

66611.5

81915.9

0.20

153

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

693

4995

1.48

17.58

2.9

2.7

e6/l

0.6

0.9

3.30

410

2823

(3003694) ABO and Rh group [Type] in Blood

1100

8625

1.39

17.54

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

206

1087

1.95

17.28

1.6

titre

173.0

256.7

—

(3026782) Osmolality of Urine

758

5583

1.45

17.14

3.3

2.7

mosm/kgh2o

544.0

568.1

2.04

655

4794

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

139

635

2.24

17.11

1.6

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

177

893

2.03

16.87

2.1

1.6

g/l

0.2

0.43

161

853

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2511

22464

1.37

16.84

4.2

3.6

pmol/l

15.0

14.7

7.00

2331

20680

(3003434) Protein [Mass/volume] in Pleural fluid

328

2.72

16.79

1.5

g/l

31.5

33.5

0.72

292

(3026493) Urate [Moles/volume] in Serum or Plasma

1088

8574

1.38

16.65

3.4

2.7

umol/l

2033.4

3623.5

1.21

982

7618

(3023199) Leukocytes [#/volume] in Pleural fluid

296

2.81

16.62

1.5

1.4

e6/l

7114.9

2772.1

0.43

214

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

217

1183

1.89

16.51

13.2

5.8

1.8

1.7

0.55

206

1103

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

156

758

2.10

16.45

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

152

733

2.12

16.35

1.8

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

786

5881

1.43

16.21

1.6

1.5

nmol/l

18.9

20.1

1.53

691

5115

(3020630) Protein [Mass/volume] in Serum or Plasma

358

2266

1.64

16.18

2.1

2.8

g/l

66.2

66.8

0.70

331

2113

(3029937) Albumin [Presence] in Urine by Test strip

973

7559

1.39

16.14

4.8

3.6

estimate

0.0

0.60

322

2560

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

272

1603

1.75

16.03

1.5

1.4

—

(3039000) Anion gap in Blood

144

692

2.12

15.64

18.2

7.9

mmol/l

10.6

11.5

3.30

135

621

(3018572) Chloride [Moles/volume] in Blood

144

693

2.12

15.58

18.2

7.9

mmol/l

106.0

105.2

1.35

135

622

(1616796) Gas panel - Central venous blood

137

647

2.16

15.56

6.4

4.2

—

(3000494) Fungus identified in Specimen by Culture

535

3753

1.50

15.36

1.8

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

1672

14198

1.33

15.26

4.2

3.2

estimate

0.0

0.80

334

2593

(3037522) Nuclear Ab [Titer] in Serum

589

4238

1.46

14.85

1.4

1.3

titre

485.6

479.5

0.03

128

800

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

435

2946

1.54

14.71

2.9

2.5

g/l

0.2

3.07

406

2765

(3017143) Hepatitis C virus Ab [Presence] in Serum

519

3675

1.48

14.16

1.9

1.7

—

(3047181) Lactate [Moles/volume] in Blood

178

960

1.90

14.02

16.1

6.8

mmol/l

1.3

0.38

162

837

(3015377) Calcium [Moles/volume] in Serum or Plasma

1134

9188

1.34

14.00

3.7

3.6

mmol/l

2.3

1.97

1001

8199

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

343

2225

1.60

13.98

5.5

4.4

mmol/l

1.2

1.84

311

1977

(3007930) Methemoglobin/Hemoglobin.total in Blood

207

1176

1.81

13.82

13.8

5.8

1.0

0.9

1.38

196

1100

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

273

1689

1.67

13.46

3.6

3.4

pmol/l

4.4

4.5

0.90

245

1516

(3022313) Gas panel - Capillary blood

249

1507

1.70

13.33

5.9

4.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

185

1028

1.84

13.28

6.3

5.6

mg/l

1.7

1.4

3.30

170

965

(3034426) Prothrombin time (PT)

140

3.39

13.27

1.2

1.3

—

(3024932) HLA-DR beta [Type]

161

3.20

13.13

1.1

—

(3026008) Bacteria identified in Urine by Culture

850

6651

1.36

13.05

3.1

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

178

986

1.85

12.92

1.7

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1652

14212

1.29

12.90

5.5

4.4

estimate

0.0

0.80

343

2700

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

627

4675

1.41

12.88

3.0

2.9

e6/l

1.6

0.00

345

2510

(3024471) HLA-A [Type]

163

3.16

12.87

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

286

2.58

12.71

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

563

4131

1.43

12.64

1.8

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1664

14371

1.29

12.45

4.3

3.2

estimate

0.0

0.11

333

2520

(44806118)

382

2.34

12.30

1.8

1.7

—

(44790047)

382

2.34

12.30

1.8

1.7

—

(44790049)

382

2.34

12.30

1.8

1.7

—

(44790048)

382

2.34

12.30

1.8

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1308

10981

1.30

12.08

2.0

1.9

pmol/l

95.5

95.8

0.08

736

6009

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

219

1318

1.70

11.98

6.4

4.1

mmol/l

24.9

24.7

0.22

210

1237

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

136

708

1.96

11.94

2.0

1.6

u/ml

110.5

113.0

0.10

125

(40767503) Oxygen content in Capillary blood by calculation

125

632

2.01

11.92

3.3

2.6

16.5

16.9

0.40

327

(3011397) Hemoglobin [Presence] in Urine by Test strip

834

6592

1.34

11.83

4.2

3.2

—

(4010399)

326

2172

1.55

11.81

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

194

2.86

11.73

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1149

9510

1.30

11.73

4.7

4.1

mg/mmol

18.3

9.3

3.26

784

6290

(3002385) Erythrocyte distribution width [Ratio]

2830

26284

1.33

11.67

27.8

16.1

13.9

13.6

12.23

2796

25740

(3012516) Albumin [Mass/volume] in Urine

1101

9066

1.31

11.67

3.9

3.3

mg/l

241.2

367.3

0.66

771

5987

(3012441) Differential panel - Pleural fluid

257

2.60

11.66

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

187

1086

1.76

11.63

1.9

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

112

553

2.06

11.42

1.8

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

134

3.24

11.35

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

129

3.28

11.34

1.0

1.1

—

(3002256) Pathology report gross observation

509

3743

1.42

11.21

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

141

3.15

11.10

1.8

1.6

161.2

157.1

0.12

132

(40761535) Cells panel - Urine sediment

339

2322

1.51

10.80

4.8

3.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

362

2514

1.49

10.78

2.8

g/l

11.0

10.6

0.87

326

2324

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

374

2.25

10.69

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

387

2.22

10.68

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3066

28919

1.36

10.65

6.2

5.5

mmol/mol

39.5

39.8

0.45

2926

27226

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.27

10.58

1.6

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

1170

9812

1.28

10.54

3.8

3.3

mmol/l

7.5

8.4

9.18

1030

8431

(3010375) cycloSPORINE [Mass/volume] in Blood

212

2.67

10.50

28.2

28.0

ug/l

117.6

128.0

0.60

172

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3209

30517

1.40

10.37

4.9

4.0

mmol/l

1.4

0.23

3058

28536

(3011648) Oxygen content in Venous blood

285

2.41

10.34

3.2

3.9

11.1

11.5

0.39

285

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.32

10.27

1.5

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

7.17

10.13

1.7

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

149

850

1.78

9.89

1.7

1.3

iu/ml

13.6

8.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

137

762

1.83

9.88

2.1

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

143

807

1.80

9.84

2.9

3.7

mg/l

67.5

58.7

0.28

119

646

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

447

2.09

9.84

1.8

1.7

—

(4306422)

106

543

1.98

9.81

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

143

808

1.80

9.80

2.9

3.7

mg/l

38.7

62.3

0.76

120

648

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

164

2.83

9.68

2.8

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

135

754

1.82

9.62

3.6

3.8

mmol/l

24.3

24.7

0.56

113

658

(3035947) Staphylolysin Ab [Units/volume] in Serum

154

2.88

9.58

1.2

1.1

iu/ml

3.8

3.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

107

555

1.96

9.57

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

107

555

1.96

9.57

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

290

1972

1.51

9.56

1.6

1.9

g/l

1.1

1.3

0.74

266

1837

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.64

9.53

4.3

6.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

140

793

1.80

9.53

2.8

3.6

ratio

15.3

1.6

—

(3045788) Cell count panel - Pleural fluid

229

2.51

9.51

1.4

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

137

772

1.80

9.49

2.0

1.6

u/ml

10.2

18.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

292

2.32

9.37

1.6

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

118

637

1.88

9.37

2.9

2.3

g/l

128.9

133.1

0.81

460

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.16

9.35

1.3

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

649

5104

1.33

9.29

2.0

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

118

639

1.87

9.28

1.7

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

599

4665

1.34

9.15

2.8

3.3

mmol/l

2.4

0.07

506

4124

(3028626) Oxygen [Partial pressure] in Capillary blood

138

792

1.77

9.00

5.3

4.3

kpa

8.7

8.6

0.22

127

736

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

3.84

8.95

2.2

1.3

100.1

108.5

0.44

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

132

752

1.78

8.84

1.5

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

155

925

1.71

8.82

2.2

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

135

775

1.77

8.81

1.5

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

165

1003

1.68

8.77

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1287

11110

1.24

8.66

4.5

3.3

—

(3052851) Hemolysis interference index of Serum or Plasma

148

880

1.71

8.54

4.5

3.2

—

(21494755) Public health laboratory ask at order entry panel

277

3928

0.68

8.54

1.3

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

128

734

1.77

8.40

1.6

1.3

u/ml

253.0

264.0

0.19

100

461

(3014148) Varicella zoster virus Ab [Titer] in Serum

406

2.04

8.40

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

788

6443

1.28

8.37

1.3

u/ml

2.3

2.0

0.19

242

1734

(3004588) Protein electrophoresis panel - Serum or Plasma

269

1853

1.49

8.34

1.9

2.4

—

(40768806) Pleura Pathology biopsy report

263

2.30

8.32

1.5

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

449

1.98

8.30

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3168

30262

1.34

8.29

5.0

4.3

mmol/l

6.0

0.05

2982

28091

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3278

31476

1.38

8.29

5.3

4.4

mmol/l

1.4

8.03

3140

29576

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

498

1.93

8.29

1.5

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3327

32031

1.40

8.22

5.9

4.8

mmol/l

2.6

2.8

32.64

3196

30080

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

162

2.67

8.21

1.4

1.3

u/l

15.7

12.4

0.31

154

(3021879) Hepatitis B virus core Ab [Presence] in Serum

333

2401

1.43

8.14

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

352

2.10

8.03

1.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

175

1108

1.61

7.95

1.3

1.2

u/ml

1.8

0.8

0.27

(3019150) Specific gravity of Urine by Refractometry

755

6182

1.28

7.88

4.7

3.5

kg/l

1.0

0.14

102

845

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3289

31639

1.37

7.86

5.4

4.4

mmol/l

4.5

4.7

36.07

3160

29863

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

111

623

1.81

7.85

3.5

3.9

59.0

57.0

0.97

111

623

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

100

547

1.85

7.69

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

331

2411

1.41

7.64

4.6

3.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.10

7.27

1.2

67.7

85.8

1.16

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.30

7.21

2.0

2.1

ng/l

126.9

157.0

0.34

(3007164) IgA [Mass/volume] in Serum or Plasma

718

5914

1.27

7.06

1.5

g/l

2.8

2.5

2.49

496

3765

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

483

1.86

7.05

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

290

2.12

7.01

5.7

3.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

108

623

1.76

7.01

3.1

3.8

—

(40768446) Kidney Pathology biopsy report

172

2.46

6.83

1.8

—

(3021901) Oxygen saturation in Capillary blood

527

1.80

6.73

3.9

3.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

104

602

1.75

6.68

1.3

1.2

u/ml

3.3

9.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.35

6.54

1.3

1.1

82.5

80.9

0.09

(3000492) Spirometry study

435

3398

1.32

6.43

1.6

1.4

—

(3004451) EKG impression Narrative

159

2.47

6.42

1.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.93

6.42

1.1

1.0

68.4

89.1

2.21

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3459

33696

1.44

6.38

14.1

10.3

u/l

29.0

29.7

0.97

3378

32731

(40760892) CBC W Ordered Manual Differential panel - Blood

825

6978

1.23

6.35

5.7

4.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

658

1.69

6.31

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

159

1044

1.55

6.25

4.0

3.7

g/l

0.5

0.3

0.98

521

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

430

1.86

6.24

1.4

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

562

1.75

6.24

1.7

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

101

592

1.73

6.24

1.2

u/ml

2.6

7.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.30

6.13

1.2

1.1

74.1

72.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

121

749

1.64

6.10

1.3

1.2

u/ml

3.6

7.1

0.32

(3037756) Immunofixation for Serum or Plasma

552

1.74

6.06

1.6

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

121

757

1.62

5.86

1.3

1.2

u/ml

13.1

7.8

0.35

108

(3051651) Icteric interference index of Serum or Plasma

198

2.24

5.85

6.6

4.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

377

2926

1.32

5.83

2.9

2.7

u/l

44.8

55.2

0.24

322

2568

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

333

1.94

5.82

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

251

2.09

5.81

1.8

2.1

—

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

199

1394

1.45

5.74

2.0

u/l

40.4

39.3

0.28

165

1247

(3048929) Epstein Barr virus Ab [Presence] in Serum

161

1082

1.51

5.71

1.5

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

133

857

1.57

5.71

1.4

ug/g

235.5

270.7

1.27

508

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

280

2.02

5.70

1.4

1.2

—

(3025941) Bacteria identified in Stool by Culture

226

1626

1.42

5.64

1.4

1.3

—

(3000012) Reticulocyte production index

145

2.43

5.61

1.1

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.89

5.61

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

127

813

1.58

5.61

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

146

965

1.53

5.60

2.8

2.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

160

2322

0.67

5.57

1.6

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

203

1443

1.43

5.43

3.3

2.9

e6/l

0.3

0.06

198

1406

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

971

8475

1.20

5.31

1.7

mmol/l

1.5

0.92

855

7186

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

672

5662

1.23

5.28

1.6

pmol/l

59240501.5

34560618.9

0.36

579

4809

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

522

1.70

5.27

6.9

4.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

367

1.84

5.25

1.9

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

228

2.08

5.22

1.7

1.8

—

(3011985) Renin [Units/volume] in Plasma

420

1.78

5.17

1.3

1.4

mu/l

151.4

58.2

0.92

384

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.94

5.14

1.5

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

274

3582

0.75

5.12

1.8

—

(3007461) Platelets [#/volume] in Blood

3575

35161

1.57

5.12

34.1

19.3

e9/l

234.9

248.3

32.32

3523

34383

(3034770) Mitochondria Ab [Titer] in Serum

140

938

1.51

5.08

1.3

titre

—

1393.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

314

2426

1.32

5.03

4.3

4.5

0.2

0.00

105

692

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.67

4.92

1.6

1.3

mmol/l

0.5

0.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

144

978

1.49

4.91

1.7

1.6

iu/ml

6.1

0.3

0.46

201

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

123

809

1.54

4.87

1.3

1.2

u/ml

28.8

34.3

—

(3035941) MCH [Entitic mass]

3575

35181

1.55

4.86

34.0

19.2

30.3

30.4

4.85

3549

34784

(3003181) Sodium [Moles/volume] in Urine

474

1.70

4.84

1.6

1.4

mmol/l

61.7

65.8

0.34

381

(3024731) MCV [Entitic volume]

3575

35186

1.55

4.79

34.0

19.2

90.8

0.46

3549

34789

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

150

2.28

4.79

1.2

1.1

u/l

61.0

23.0

0.52

114

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

9.02

4.78

7.2

9.8

47.4

60.6

—

(3026361) Erythrocytes [#/volume] in Blood

3575

35188

1.54

4.77

34.1

19.3

e12/l

4.4

4.6

66.88

3519

34320

(3036481) Cortisol [Moles/volume] in Serum or Plasma

352

2784

1.29

4.76

2.4

nmol/l

373.2

364.4

0.23

328

2607

(3010813) Leukocytes [#/volume] in Blood

3575

35192

1.54

4.72

34.2

19.3

e9/l

6.8

6.6

5.38

3517

34322

(3007566) Smooth muscle Ab [Titer] in Serum

140

954

1.49

4.71

1.3

titre

85.0

104.0

0.34

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

287

1.89

4.68

3.3

2.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

130

874

1.51

4.67

2.1

2.0

mg/l

13.5

10.8

0.72

121

820

(3000963) Hemoglobin [Mass/volume] in Blood

3575

35198

1.53

4.64

34.4

19.4

g/l

133.2

139.6

99.65

3547

34798

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1263

11380

1.17

4.61

2.7

2.3

nmol/l

75.8

75.1

0.38

1161

10414

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

398

1.75

4.61

1.2

1.4

pmol/l

322.3

286.6

0.28

313

(3017181) Myelocytes/100 leukocytes in Blood

325

2556

1.30

4.59

4.4

4.5

1.4

0.9

0.78

111

751

(3039162) Centromere protein B Ab [Units/volume] in Serum

355

1.79

4.55

1.2

1.3

u/ml

39.2

55.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

276

1.90

4.54

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

276

1.90

4.54

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

276

1.90

4.54

1.6

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.77

4.53

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.21

4.33

1.3

mmol/l

1.5

1.6

—

(1761868) Lipid panel - Serum or Plasma

1158

12812

0.86

4.30

3.1

2.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

191

2.05

4.28

1.1

1.2

ratio

1.0

—

(3019225) pH of Specimen

336

2687

1.28

4.18

6.0

4.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

307

1.80

4.13

1.2

u/l

61.9

63.5

0.05

206

(3023487) Leukocytes [#/volume] in Peritoneal fluid

135

2.23

4.08

2.7

2.3

e6/l

21720.8

827.7

0.47

100

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

116

2.34

4.08

2.9

2.1

e6/l

1851.7

2547.6

0.39

(40768797) Stomach Pathology biopsy report

497

4168

1.22

4.05

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

296

1.80

3.99

3.7

2.4

—

(3035285) Chloride [Moles/volume] in Venous blood

305

1.78

3.92

3.6

2.4

mmol/l

105.4

105.6

0.11

300

(3041354) Potassium [Moles/volume] in Venous blood

305

1.78

3.92

3.6

2.4

mmol/l

4.1

0.07

300

(3049717) Cytology report of Urine Cyto stain

155

1119

1.40

3.89

2.5

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

314

1.76

3.86

10.6

5.4

mmol/l

7.0

7.3

0.28

263

(3002179) Metamyelocytes/100 leukocytes in Blood

294

2339

1.28

3.83

4.4

4.3

0.6

0.01

541

(42529406) Shigella sp [Presence] in Stool by Culture

120

831

1.46

3.79

1.4

1.2

—

(3035880) pH of Pleural fluid

133

2.19

3.79

1.2

1.4

—

(3025159) Blasts/100 leukocytes in Blood

286

2273

1.28

3.76

4.5

4.6

0.0

0.4

1.08

570

(3014765) Yersinia sp identified in Stool by Organism specific culture

119

825

1.46

3.74

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

457

1.61

3.66

1.3

1.2

—

(3019977) pH of Arterial blood

155

2.07

3.66

3.6

2.9

7.4

0.01

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

108

739

1.48

3.64

1.8

2.2

g/l

0.0

0.00

689

(3033799) Differential panel - Peritoneal fluid

116

2.25

3.64

2.9

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

444

1.61

3.59

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

143

2.11

3.58

1.4

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

143

2.11

3.58

1.4

2.0

—

(3044927) Protein electrophoresis panel - Urine

270

1.79

3.57

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2176

20605

1.14

3.56

2.9

2.8

—

(40768800) Prostate Pathology biopsy report

821

0.58

3.56

1.2

—

(3022145) Colonoscopy Study observation

417

3483

1.22

3.55

1.3

1.4

—

(3047189) Immunofixation for 24 hour Urine

137

2.13

3.54

1.3

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

117

820

1.44

3.50

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

186

1.94

3.47

1.4

1.5

u/l

20.7

5.1

0.89

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

576

1.52

3.45

1.1

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

159

2.02

3.44

1.8

2.4

umol/l

16.8

28.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

106

732

1.46

3.43

1.8

2.2

g/l

0.0

0.00

688

(3004347) Hepatitis D virus Ab [Presence] in Serum

7.01

3.36

1.0

—

(4094501)

140

1023

1.38

3.32

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

141

2.07

3.31

3.6

2.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

114

805

1.43

3.29

1.8

2.1

g/l

36.4

38.0

1.77

101

719

(3045414) Leukocytes [Presence] in Urine

170

1283

1.34

3.29

1.9

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

128

2.12

3.29

1.4

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

149

2.02

3.25

1.0

1.1

iu/ml

206.4

175.6

0.27

149

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

593

1.50

3.24

2.0

2.3

u/l

4777.2

2771.7

0.21

221

(3023419) Bacteria identified in Sputum by Culture

379

1.62

3.20

2.6

2.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

955

1.39

3.17

1.8

2.3

g/l

11.3

10.3

1.24

112

831

(3042631) Mycobacterium sp identified in Specimen

388

1.61

3.16

2.3

2.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

350

1.64

3.14

1.6

1.3

g/l

3.0

2.9

0.14

246

(3027135) IgG subclass 1 [Mass/volume] in Serum

350

1.64

3.14

1.6

1.3

g/l

8.1

6.6

0.82

247

(3024139) IgG subclass 3 [Mass/volume] in Serum

350

1.64

3.14

1.6

1.3

g/l

0.4

0.10

244

(3024263) Appearance of Synovial fluid

179

1.91

3.14

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

134

983

1.38

3.13

1.8

2.3

g/l

3.3

3.0

1.83

108

785

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

118

848

1.40

3.11

1.7

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

501

1.53

3.11

1.1

g/l

1.6

1.5

0.69

456

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

112

798

1.42

3.10

1.8

2.2

g/l

0.0

0.17

102

747

(3035637) Corticotropin [Mass/volume] in Plasma

430

1.57

3.09

1.4

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1037

1.36

3.08

1.8

2.3

g/l

7.0

7.3

1.14

112

809

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1037

1.36

3.08

1.8

2.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.45

3.04

3.4

3.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

160

1.95

3.04

1.4

—

(3017732) Neutrophils [#/volume] in Blood

264

2138

1.25

3.02

2.8

3.1

e9/l

4.3

4.1

0.67

209

1753

(3003338) MCHC [Mass/volume]

2849

27584

1.15

2.97

29.7

16.6

g/l

332.5

334.1

18.18

2835

27419

(3026389) Candida sp identified in Specimen by Organism specific culture

340

1.63

2.97

1.2

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.64

2.96

1.1

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

123

900

1.38

2.94

1.9

2.4

g/l

0.7

1.0

0.45

107

800

(1761482) Bacteria [#/volume] in Urine by Culture

583

1.47

2.90

3.9

3.7

—

(4024509)

214

1.78

2.87

1.6

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

601

1.46

2.87

1.3

1.2

u/ml

29.6

49.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.39

2.87

8.1

10.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

157

1.92

2.84

1.4

—

(4062490)

352

1.60

2.84

1.6

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

138

1037

1.34

2.80

1.8

2.3

g/l

4.2

3.8

1.24

106

768

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.23

2.77

2.9

4.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.17

2.76

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

105

757

1.40

2.76

2.1

1.7

e6/l

26613.3

12818.3

0.59

554

(3017704) Immunofixation for Urine

159

1.89

2.75

1.6

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

111

2.08

2.72

2.9

2.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

248

1.70

2.72

2.3

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

357

1.58

2.70

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

342

1.59

2.68

2.7

2.8

e9/l

1.0

1.2

0.87

204

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

382

1.55

2.66

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

257

2112

1.23

2.61

1.8

1.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.01

2.56

6.4

5.6

umol/l

444.8

467.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.23

2.53

1.6

1.4

mmol/l

4.3

3.8

0.14

(3024980) IgG subclass 4 [Mass/volume] in Serum

567

1.44

2.53

1.8

1.7

g/l

0.9

0.8

0.22

442

(3010144) Erythrocytes [#/volume] in Synovial fluid

300

1.61

2.53

1.8

1.4

e6/l

141668.2

74421.3

0.32

210

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

113

839

1.36

2.51

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

510

1.46

2.51

1.5

—

(3021788) Differential panel - Synovial fluid

569

1.43

2.49

1.9

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

278

1.63

2.49

1.2

1.3

titre

246.7

177.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.32

2.48

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.32

2.48

1.2

1.1

93.7

93.5

0.01

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

545

1.44

2.47

1.3

u/l

27.3

44.5

0.97

471

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

576

5107

1.15

2.47

1.3

iu/ml

27.4

32.3

0.51

170

1609

(40768443) Skin Pathology biopsy report

158

1235

1.29

2.47

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.82

2.46

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

382

1.53

2.45

1.4

1.3

nmol/l

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

288

1.60

2.42

2.2

1.5

19.2

31.1

2.18

182

(3052592) Norovirus Ag [Presence] in Stool

2.76

2.37

1.4

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

575

1.42

2.37

1.1

—

(3036603) Volume of Urine

198

1.72

2.35

1.6

1698.2

1995.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

354

1.53

2.35

1.3

u/l

29.7

27.7

0.18

286

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

2.34

5.2

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

2.34

5.2

2.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

132

1700

0.77

2.33

1.5

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.22

2.30

1.6

2.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

105

2.01

2.30

2.0

1.3

57.7

52.2

0.26

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

292

1.58

2.30

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.86

2.30

1.2

1.1

—

(3016750) Collection duration of Urine

200

1.71

2.28

2.6

2.2

min

520.0

491.0

0.91

149

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

246

1.63

2.27

3.0

2.9

e9/l

0.2

0.06

211

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

141

1.85

2.27

1.7

nmol/l

3.4

8.0

0.71

118

(3008757) Leukocyte morphology finding [Identifier] in Blood

325

1.55

2.27

2.8

4.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

398

1.49

2.26

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.89

2.25

1.9

3.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

201

1.70

2.24

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

735

1.36

2.24

1.6

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

764

8368

0.89

2.18

2.5

2.7

ug/l

0.7

0.79

495

5082

(3004716) Salmonella sp identified in Stool by Organism specific culture

181

1464

1.25

2.17

1.5

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.00

2.14

1.6

2.2

—

(40768793) Breast Pathology biopsy report

437

0.57

2.14

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

108

820

1.33

2.12

1.1

—

(44813793)

197

1.68

2.12

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

152

1.78

2.11

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

152

1.78

2.11

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

439

4966

0.87

2.08

1.9

1.6

1.5

2.13

390

4430

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.26

2.07

1.2

2.4

—

(3044941) Cell count panel - Synovial fluid

506

1.41

2.07

1.9

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

146

1.79

2.06

1.0

1.1

miu/ml

1472.7

1486.0

0.02

146

(4146454)

325

1.51

2.06

2.7

2.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.50

2.05

9.0

5.1

—

(3038515) Glucose [Moles/volume] in Venous blood

525

1.40

2.03

5.3

3.1

mmol/l

7.4

0.01

508

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.40

2.02

8.4

9.0

mmol/l

5.2

6.8

1.39

(3043410) Blood group antigens tested for on Red Blood Cells

2.05

2.01

2.6

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

412

3623

1.15

2.00

2.5

2.6

ug/g

139.0

143.3

0.09

332

2941

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

255

1.57

2.00

2.9

e6/l

334.1

533.6

2.91

213

(3006922) Hepatitis E virus Ab [Presence] in Serum

255

1.57

2.00

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

170

1.71

2.00

2.7

2.3

umol/l

46.3

55.3

0.86

148

(3041096) Erythrocytes [Presence] in Urine by Automated

855

7880

1.11

1.95

3.8

2.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

170

1385

1.24

1.94

2.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

127

1.82

1.93

1.1

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

363

1.47

1.93

1.6

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.45

1.93

2.6

2.3

—

(4034850)

128

1010

1.28

1.92

18.5

8.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

565

1.37

1.92

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

165

1.70

1.90

1.3

1.4

u/ml

26.5

23.8

—

(3044007) Cell count panel - Peritoneal fluid

106

1.89

1.90

3.5

2.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

106

1.89

1.90

3.5

3.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

566

1.37

1.90

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

158

1.71

1.88

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

158

1.71

1.88

1.6

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

158

1.71

1.88

1.6

2.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

1.82

1.88

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.19

1.88

1.9

3.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.19

1.88

1.0

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

483

1.39

1.86

2.7

3.7

0.8

1.5

2.17

378

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

350

1.46

1.85

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

350

1.46

1.85

1.6

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.53

1.83

1.8

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

351

1.46

1.82

1.6

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

426

1.42

1.82

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

108

1.86

1.81

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.06

1.80

1.0

1.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.05

1.80

1.9

1.5

mg/l

0.6

2.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.05

1.80

1.9

1.5

mg/l

4.4

2.5

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.05

1.80

1.9

1.5

mg/l

0.7

2.3

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.05

1.80

1.9

1.5

mg/l

0.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

131

1.76

1.77

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

131

1.76

1.77

1.4

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

272

1.51

1.76

2.0

2.5

17.6

12.7

0.90

139

(3042111) Morphology [Interpretation] in Bone marrow Narrative

472

1.38

1.75

1.9

1.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.34

1.74

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

147

1.71

1.73

2.3

1.4

2.5

4.4

0.47

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.92

1.72

1.9

1.5

mg/l

0.4

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

171

1.64

1.70

1.6

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.06

1.70

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

358

1.43

1.67

1.6

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.80

1.65

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

342

0.58

1.64

3.9

3.5

u/ml

21.9

26.5

0.28

332

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.98

1.64

1.1

1.5

29.7

28.5

0.06

(3024522) Salmonella sp identified in Specimen by Organism specific culture

360

1.42

1.63

1.6

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

197

1.58

1.62

1.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

158

1.65

1.62

1.6

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

583

1.33

1.61

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.57

1.61

1.0

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

218

1861

1.18

1.59

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

152

1255

1.22

1.59

3.7

3.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

152

1.65

1.56

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2998

29416

1.10

1.55

25.3

14.1

39.3

41.0

20.37

2200

22614

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

397

3551

1.13

1.55

5.2

4.3

30.9

31.0

0.05

315

2512

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2307

22389

1.08

1.53

3.9

3.3

u/l

61.7

52.0

3.80

2188

21178

(3001729) Color of Synovial fluid

2.86

1.50

2.8

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

131

1.68

1.49

1.5

2.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

170

1.59

1.48

1.6

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

125

1020

1.23

1.48

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.44

1.47

1.9

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

243

1.49

1.47

1.3

mmol/l

10.8

11.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

243

1.49

1.47

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1236

0.80

1.46

2.3

1.7

mg/l

3.5

4.3

0.58

884

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

582

5340

1.11

1.46

1.6

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

163

1.60

1.46

1.2

1.5

ug/l

4.3

5.7

0.33

134

(3037692) Legionella sp identified in Specimen by Organism specific culture

117

1.71

1.44

2.1

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

244

1.48

1.44

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1178

0.79

1.44

1.5

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

344

1.40

1.44

1.4

promille

1.3

1.5

0.51

269

(3005322) IgE [Units/volume] in Serum or Plasma

229

1982

1.17

1.44

1.2

1.3

u/ml

207.7

224.6

0.17

212

1837

(21494815) CD4 cells/100 lymphocytes in Specimen

336

1.40

1.43

2.4

2.6

31.0

42.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.97

1.43

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.25

1.40

1.0

1.1

—

(40768804) Tissue Pathology biopsy report

1232

11709

1.08

1.38

2.0

—

(3004775) Volume in Urine collected for unspecified duration

263

1.45

1.38

2.6

2.3

755.8

640.9

0.81

181

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

337

0.62

1.38

1.3

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

627

1.28

1.35

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

191

1.52

1.34

3.3

2.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

442

0.68

1.34

1.2

1.4

pmol/l

75.9

134.0

0.40

140

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

147

0.48

1.31

3.0

2.2

nmol/l

171.3

148.9

—

129

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

577

1.29

1.31

1.5

1.6

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

1.30

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.10

1.30

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

159

0.50

1.24

1.3

3.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

240

0.58

1.22

1.0

ng/l

922.1

762.9

—

171

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.63

1.21

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

341

3772

0.89

1.20

2.3

nmol/l

12.8

13.7

1.56

303

3396

(3008295) Osmolality of Serum or Plasma

332

1.36

1.18

1.5

1.4

mosm/kgh2o

278.5

282.5

0.40

258

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

793

1.23

1.18

1.1

u/ml

3.8

6.2

0.45

118

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

376

1.33

1.17

1.9

1.6

71.5

59.0

1.78

234

(3043238) Trisomy 21 risk [Likelihood] in Fetus

261

0.61

1.16

1.3

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.05

1.15

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

224

1.43

1.14

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

258

1.40

1.13

2.0

2.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

327

1.35

1.12

1.7

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

618

1.25

1.12

3.6

3.8

u/ml

700.0

701.8

0.00

578

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

389

1.32

1.10

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

120

1.59

1.08

2.7

2.1

—

(3017509) Phencyclidine [Presence] in Urine

2.19

1.08

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.65

1.06

1.9

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

254

0.63

1.06

1.3

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

2.12

1.05

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

121

1.57

1.05

1.8

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

121

1.57

1.05

1.8

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

121

1.57

1.05

1.8

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

313

0.67

1.04

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

313

0.67

1.04

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

313

0.67

1.04

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

253

0.63

1.04

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

312

0.67

1.03

1.3

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

520

4833

1.09

1.03

1.3

u/ml

7.1

12.0

1.43

212

1969

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.06

1.02

1.0

1.1

—

(40768441) Liver Pathology biopsy report

238

1.39

1.02

1.8

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.77

1.00

2.2

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

332

0.69

0.98

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

318

1.32

0.97

2.0

2.1

mg/l

16.4

21.7

0.52

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

292

1.34

0.97

1.8

1.5

g/l

1.0

0.08

292

(3017354) Segmented neutrophils/100 leukocytes in Blood

292

1.34

0.97

2.5

3.7

61.6

57.0

0.59

188

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

362

1.30

0.97

1.3

1.5

nmol/l

0.7

0.3

0.91

275

(3023410) Appearance of Cerebral spinal fluid

354

0.70

0.97

2.3

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

102

861

1.19

0.95

1.3

miu/ml

211.2

206.1

0.04

370

(3024869) Neuronal Ab [Presence] in Serum

1.73

0.92

1.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

373

0.72

0.92

1.0

1.1

u/ml

0.2

0.3

—

(3014891) Appearance of Pleural fluid

2.14

0.91

3.3

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

287

1.33

0.91

2.9

2.6

e6/l

457.7

674.4

1.93

104

(3022621) pH of Urine by Test strip

193

1718

1.13

0.90

3.1

2.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.91

0.88

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

307

1.31

0.87

2.8

1.4

iu/ml

32.3

28.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.00

0.87

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

179

0.61

0.84

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

213

1.36

0.84

1.5

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

137

1.46

0.84

2.1

2.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.61

0.81

1.2

1.3

g/l

42.3

38.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.70

0.80

1.0

1.2

—

6.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.67

0.78

3.1

2.8

mmol/l

1.2

0.12

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

216

1.35

0.78

1.5

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

211

0.66

0.78

15.6

11.7

mmol/l

0.6

0.06

194

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

304

1.29

0.78

1.5

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.08

0.74

2.6

5.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.08

0.74

2.6

5.5

—

(40757373) Influenza virus identified in Isolate

1.61

0.72

1.9

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.67

0.72

1.2

2.7

—

(3025130) Human papilloma virus identified in Specimen

255

1.30

0.71

1.8

1.9

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.75

0.71

4.0

11.1

—

(3001556) Androgen free Index in Serum or Plasma

1.92

0.70

1.8

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

203

1.33

0.70

1.0

1.6

u/l

5.5

7.4

1.10

174

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

126

1.43

0.70

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.49

0.70

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.51

0.69

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

102

1.47

0.67

1.7

2.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

757

0.84

0.67

1.7

1.8

e6/l

3856.3

1332.5

0.56

610

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.49

0.66

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.49

0.66

1.1

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

756

0.84

0.66

1.7

e6/l

19.4

23.8

0.12

577

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

223

1.30

0.66

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.79

0.66

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.79

0.66

1.0

—

(3011288) Drugs identified in Urine by Screen method

820

0.85

0.66

3.1

3.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.54

0.65

2.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

661

1.17

0.65

2.2

1.9

iu/l

3.7

5.0

1.11

240

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

206

1.31

0.65

1.1

1.2

—

(21494434) Karyotype in Bone marrow

268

1.27

0.65

1.1

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1102

11379

0.95

0.64

3.6

3.7

22.7

21.4

1.59

477

4953

(36660697) Celiac disease serology panel - Serum

252

2328

1.09

0.64

1.1

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

686

0.84

0.62

1.8

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

279

1.26

0.62

3.4

4.1

—

(4133840)

113

1.42

0.61

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

798

1.14

0.60

2.8

2.4

ug/min

117.8

125.0

0.07

515

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.54

0.59

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.54

0.59

1.5

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

199

1828

1.09

0.59

1.2

iu/ml

121.5

148.5

0.44

672

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.44

0.59

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.56

0.58

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

185

0.70

0.58

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

149

1.34

0.57

3.5

3.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.43

0.56

1.6

1.7

mmol/l

5.5

8.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.57

0.56

1.0

1.1

—

5.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

719

1.14

0.55

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

382

0.81

0.53

1.2

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.52

0.52

1.6

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

197

1.27

0.51

1.7

2.0

u/field

1.0

1.7

—

100

(3051387) C reactive protein [Mass/volume] in Capillary blood

557

1.15

0.49

4.0

3.4

mg/l

22.8

24.6

0.18

336

(3000034) Microalbumin [Mass/volume] in Urine

307

1.21

0.49

2.4

2.9

mg/l

73.3

58.0

0.12

230

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

155

0.71

0.48

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

119

1.35

0.48

2.0

2.7

e6/l

224.3

200.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.45

0.48

1.4

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.45

0.48

1.4

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.45

0.48

1.4

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.45

0.48

1.4

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

172

1.28

0.48

5.9

6.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

484

1.16

0.48

1.1

au/ml

10.2

9.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.49

0.47

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

439

0.84

0.45

1.0

1.1

u/ml

2.2

2.9

0.22

180

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.40

0.45

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

362

0.83

0.44

2.0

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

229

1.22

0.43

2.3

2.7

39.8

38.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.41

0.43

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

230

1.22

0.42

2.1

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.38

0.42

1.1

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

140

1.29

0.42

1.8

1.9

umol/l

1.8

2.0

0.64

130

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.38

0.41

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.52

0.41

1.0

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

0.7

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.36

0.41

2.1

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.5

—

10.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.47

0.40

1.0

1.4

umol/24h

1.6

1.8

—

(4038314)

0.00

0.40

0.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.34

0.39

1.2

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.43

0.39

1.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

279

1.18

0.38

1.3

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

307

1.17

0.38

1.1

mg/l

315.3

280.6

1.35

283

(3016879) Cocaine [Presence] in Urine

109

1186

0.92

0.38

2.2

2.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

261

1.19

0.38

4.5

4.9

u/ml

21.0

43.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.34

0.38

2.0

2.3

umol/l

14.7

18.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.32

0.37

3.1

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

112

0.71

0.37

1.1

1.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.35

0.37

1.0

1.2

nmol/l

5.3

3.8

—

(4198724)

170

1.24

0.37

1.6

2.8

—

(3020491) Glucose [Moles/volume] in Blood

225

1.20

0.37

1.5

1.9

mmol/l

6.1

6.9

1.24

149

(3006462) Nitrate [Presence] in Urine

116

1.29

0.37

2.3

2.9

—

(3000764) Benzodiazepines [Presence] in Urine

117

1266

0.92

0.36

2.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

687

1.11

0.36

1.6

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1004

0.91

0.35

1.8

1.7

mu/l

346.7

288.2

1.02

933

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

123

0.73

0.35

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

126

1.27

0.35

2.9

2.8

umol/l

33.8

30.3

0.67

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

134

0.75

0.35

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

311

1.16

0.34

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

584

0.89

0.34

1.3

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

126

1172

1.08

0.34

1.4

1.5

iu/l

29.4

28.9

0.05

105

973

(1002224) Polysomnography panel

162

1723

0.94

0.33

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

166

0.78

0.33

1.2

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

551

0.89

0.33

4.5

5.5

umol/l

367.5

368.5

0.02

490

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

119

1107

1.08

0.32

1.6

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

229

1.18

0.32

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

229

1.18

0.32

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

602

0.90

0.32

1.1

iu/ml

168.4

1001.8

0.45

139

(3028300) Cannabinoids [Presence] in Urine

119

1277

0.93

0.32

2.5

2.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

101

1.29

0.31

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.31

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

230

1.18

0.31

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

432

0.88

0.31

1.2

mmol/l

7.3

7.4

0.03

320

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.32

0.30

1.1

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.32

0.30

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.32

0.30

1.1

1.3

—

(4211845)

129

1.24

0.30

2.3

2.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

185

0.81

0.29

1.2

1.4

—

(3027008) Opiates [Presence] in Urine

119

1272

0.93

0.29

2.1

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

525

0.89

0.29

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.25

0.29

1.9

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

107

0.75

0.29

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

108

0.74

0.29

1.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

184

0.81

0.28

1.1

u/l

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1.16

0.27

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1.16

0.27

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1.16

0.27

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

595

1.09

0.27

2.5

2.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.23

0.27

4.1

6.1

g/mol

27.8

41.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

298

3093

0.96

0.27

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

988

0.93

0.27

2.3

2.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

131

1237

1.06

0.25

2.2

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

464

1.10

0.24

1.2

—

(4015189)

1.18

0.24

3.2

2.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1406

14238

0.98

0.24

3.8

4.2

ug/l

1.8

2.1

2.50

1271

13025

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

1.17

0.24

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.74

0.24

1.0

1.1

—

(4035726)

270

2606

1.04

0.23

1.6

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

218

1.15

0.23

2.5

2.6

umol/l

6.4

9.1

0.71

156

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.75

0.22

1.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

118

1245

0.95

0.22

2.1

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

155

1481

1.05

0.21

1.1

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.19

0.21

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.8

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

0.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.5

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

4.3

—

4.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

105

0.76

0.21

5.3

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

105

0.76

0.21

10.5

5.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

269

2604

1.04

0.21

1.8

1.9

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.21

0.0

3.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.20

0.19

1.0

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

212

1.13

0.19

1.1

1.3

u/ml

0.2

0.8

1.14

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.18

0.19

2.3

3.6

umol/l

44.7

45.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.18

0.19

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

1075

1.05

0.19

1.5

u/l

10.3

7.4

1.23

862

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

146

1.17

0.19

1.8

umol/l

28.0

29.0

0.16

139

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.13

0.18

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

384

0.91

0.18

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

227

0.88

0.18

1.1

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

176

1.14

0.17

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

403

0.92

0.17

1.1

u/ml

1.8

4.2

1.52

169

(4281824)

253

1.11

0.16

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.71

0.16

1.2

1.4

—

(3014271) Vancomycin [Susceptibility]

101

1.19

0.16

2.9

2.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

447

1.07

0.16

1.0

1.1

u/ml

1.5

3.1

2.34

222

(3020874) Milk IgE Ab [Units/volume] in Serum

183

0.87

0.16

1.2

1.1

u/ml

0.5

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.13

0.16

1.5

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

467

1.07

0.15

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.78

0.15

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

197

1.12

0.15

1.5

1.3

nmol/l

1.1

1.2

0.06

149

(3017569) Oxygen content in Arterial blood

140

1.14

0.15

1.9

2.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

122

1268

0.96

0.15

2.5

2.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.10

0.15

1.1

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

244

0.90

0.14

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.18

0.14

1.6

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

109

1047

1.04

0.14

3.6

4.0

u/ml

380.7

2388.7

1.04

901

(3028707) Methadone [Presence] in Urine by Screen method

563

0.94

0.14

2.0

3.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

336

1.07

0.12

1.1

—

(3045142) Bone marrow Pathology biopsy report

356

1.07

0.12

1.2

1.4

—

(3008898) HLA-B27 [Presence]

114

1106

1.03

0.10

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

232

1.08

0.09

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.09

0.09

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

544

0.96

0.09

1.0

1.1

u/ml

1.8

2.4

—

138

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

155

1.10

0.09

2.1

2.0

ug/min

20.8

319.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

334

3387

0.98

0.09

1.5

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.09

0.08

2.3

3.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

136

1.10

0.08

1.1

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

297

0.94

0.08

1.4

1.6

—

(3028433) Virus identified in Specimen by Culture

127

1.10

0.07

1.4

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

133

0.90

0.07

3.7

4.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.81

0.07

1.2

2.5

mmol/l

1.8

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.83

0.07

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

196

1.07

0.07

1.2

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.07

0.07

1.0

—

(3020650) Glucose [Presence] in Urine

0.85

0.06

1.1

1.5

—

(40768795) Lymph node Pathology biopsy report

295

0.95

0.06

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

0.86

0.06

1.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

576

0.97

0.05

1.0

1.1

u/ml

6.2

5.0

0.21

314

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

169

1.07

0.05

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

288

1.04

0.04

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

180

0.94

0.04

1.4

1.3

nmol/l

154.0

140.2

0.53

180

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

656

1.02

0.04

1.1

u/ml

0.4

2.1

3.60

297

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

313

3152

0.99

0.03

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

131

1.07

0.03

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

289

2869

1.01

0.03

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

139

0.94

0.03

1.1

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

149

0.94

0.03

1.1

1.4

umol/l

24.3

24.0

0.01

142

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

149

0.94

0.03

3.4

2.6

umol/l

122.0

164.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

562

0.98

0.03

1.0

1.1

u/ml

0.5

1.3

1.56

267

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

108

0.93

0.03

2.5

2.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

148

0.95

0.02

1.4

2.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

769

1.01

0.02

3.2

1.9

nmol/l

1.0

0.8

1.03

648

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

281

2798

1.00

0.01

3.9

4.5

ug/l

38.8

18.8

0.31

221

2301

(4027681)

207

0.97

0.01

1.3

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

101

1002

1.01

0.01

2.3

3.2

u/ml

70.8

56.4

0.24

962

(3045716) Anion gap in Serum or Plasma

146

0.96

0.00

2.6

2.4

mmol/l

8.2

9.4

—

110

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

218

2186

1.00

0.00

2.4

au/ml

25.7

22.4

—

124

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

215

1.02

0.00

1.3

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

718

1.00

0.00

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

101

1005

1.01

0.00

2.5

2.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

259

1.00

0.00

1.0

1.2

mg/l

27.9

44.2

3.50

216

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

1.02

0.00

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.04

0.00

1.0

—

(3015183) Erythrocyte sedimentation rate

184

0.98

0.00

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

200

1999

1.00

0.00

1.3

au/ml

91.9

51.1

0.80

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

263

0.99

0.00

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

237

1.01

0.00

2.0

1.7

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

3.8

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

8.4

—

0.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

7.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.9

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.4

—

(3002619) Bacteria identified in Specimen by Culture

0.89

0.00

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.91

0.00

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.91

0.00

1.4

ug/l

10.0

8.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.01

0.00

1.3

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.5

—

1310.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

6.3

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1290.3

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3048879) Bone marrow aspiration report

0.95

0.00

2.7

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_AORTVALV_EARLY – Aortic valve malfunction, age under 60 years

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aortic valve malfunction, age under 60 years

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Aortic valve malfunction, age under 60 years (I9_AORTVALV_EARLY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints